Medical Regulation > Nova Content

New technology could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality, personalized health care. Steven... Read More »

In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia... Read More »

Competing medical device manufacturers are racing to get an artificial pancreas to the market.  The FDA has yet to approve specific artificial pancreas... Read More »

For medical uses, the only FDA-approved radio frequency identification (RFID) chip is the one made by VeriChip Corp, a division of Applied Digital Solutions... Read More »

Air Products is launching an innovative gas cylinder with built-in barrier technology to drive hygiene and safety standards in the food packaging... Read More »

New chemical analyses have found that Coca-Cola, Pepsi, Diet Coke, and Diet Pepsi contain high levels of 4-methylimidazole (4-MI), a known animal carcinogen. The... Read More »

Agilent Technologies today introduced Agilent SureFISH probes, their next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive... Read More »

Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »

Recent news reports attacking the US drug approval process are not considering all the facts. The Food and Drug Administration (FDA) has been under fire for several... Read More »

Biological pharmaceuticals are therapeutic drugs made from human or animal materials rather than chemicals, often indicated for immune system-related deficiencies... Read More »

Science Applications International Corporation (SAIC) announced today it was awarded a prime contract by the US Naval Medical Logistics Command (NMLC) to provide... Read More »

The US Food and Drug Administration (FDA) today issued three draft guidance documents on biosimilar product development to assist industry in developing these... Read More »

Two new blood thinners, Xarelto (rivaroxaban) and Pradaxa (dabigatran etexilate) have been approved by the FDA for patients with atrial fibrillation that is not... Read More »

Transparency Life Sciences, LLC (TLS), a new drug development company, has launched a thoroughly innovative platform for clinical studies, with an objective of... Read More »

Since the early 1990s, a popular procedure for relieving the pain of spinal column fractures in patients with osteoporosis was vertebroplasty – the injection of ... Read More »

A new study by food safety researchers at Drexel University demonstrates that plasma can be an effective method for killing pathogens on uncooked poultry. The most... Read More »

Pfizer announced that the U.S. Food and Drug Administration has approved their kidney cancer drug INLYTA (axinib). The treatment will be available for patients... Read More »

The horrors of Alzheimer’s disease are well known, and the specter of this disease will fall over most of us in one way or another.  Enormous quantities of ... Read More »

Merck announced today the establishment of a new Research and Development headquarters in Beijing, China, which is part of a $1.5 billion dollar investment push for... Read More »

Amgen announced today that the FDA has agreed to modify the requirements of the Nplate® Risk Evaluation and Mitigation Strategy Program (REMS). When reviewing the ... Read More »